Neorx Drugs India Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 20-05-2024
- Paid Up Capital ₹ 0.10 M
as on 20-05-2024
- Company Age 6 Year, 6 Months
- Last Filing with ROC 31 Mar 2022
- Revenue -7.30%
(FY 2022)
- Profit -1279.66%
(FY 2022)
- Ebitda -856.03%
(FY 2022)
- Net Worth -161.32%
(FY 2022)
- Total Assets -57.69%
(FY 2022)
About Neorx Drugs India
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Rambabu Medisetty, Ramadevi Veeravalli, and Umamaheswara Veravalli serve as directors at the Company.
- CIN/LLPIN
U24230TG2018PTC125158
- Company No.
125158
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Jun 2018
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Neorx Drugs India?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rambabu Medisetty  | Additional Director | 06-May-2019 | Current |
| Ramadevi Veeravalli | Director | 16-Jun-2018 | Current |
| Umamaheswara Veravalli | Director | 16-Jun-2018 | Current |
Financial Performance of Neorx Drugs India.
Neorx Drugs India Private Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 7.3% decrease. The company also saw a substantial fall in profitability, with a 1279.66% decrease in profit. The company's net worth observed a substantial decline by a decrease of 161.32%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Neorx Drugs India?
Unlock access to Neorx Drugs India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Rx Drugs Novel Care Private LimitedActive 5 years 3 months
Ramadevi Veeravalli and Umamaheswara Veravalli are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Neorx Drugs India?
Unlock and access historical data on people associated with Neorx Drugs India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Neorx Drugs India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Neorx Drugs India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
